Peter A. Thompson is Director & 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS). They have made 47 open-market trades across 14 companies since 2015, most recently 2026-07-07.
30 open-market purchases totalling $245.9M since 2015, against 17 sales. Across 29 scored buys the stock is up 2.1% at ninety days, and 2.9 points behind the S&P over the same stretch.
29 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 59% | 41% | 52% |
| Avg Move | +1.7% | -1.7% | +2.1% |
| Alpha | +1.2% | -3.1% | -2.9% |
| Scored | 29 | 29 | 29 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 29% | 57% |
| Avg Move | -3.3% | -4.2% | -1.7% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SION | SELL · 10b5-1 | 2026-07-07 | 2026-07-09 | $44.86 | $3.9M | +9.5% | -89.5% | -88.8% |
| SION | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $45.50 | $5.3M | +1.3% | +12.5% | -88.0% |
| SION | SELL · 10b5-1 | 2026-05-27 | 2026-05-29 | $44.49 | $4K | -19.0% | +2.2% | -85.6% |
| SION | SELL · 10b5-1 | 2026-05-07 | 2026-05-11 | $45.62 | $13.4M | -4.5% | -22.1% | -89.7% |
| SION | SELL · 10b5-1 | 2026-04-17 | 2026-04-21 | $44.67 | $2.5M | -6.3% | -0.2% | +10.1% |
| SION | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $44.94 | $22.9M | -14.2% | -14.9% | -3.7% |
| SION | SELL | 2026-02-02 | 2026-02-04 | $44.58 | $1.4M | -6.0% | -11.2% | +1.2% |
| SION | SELL | 2025-12-24 | 2025-12-29 | $44.55 | $3.0M | -7.5% | -0.7% | -13.6% |
| SION | SELL | 2025-12-17 | 2025-12-19 | $44.49 | $83K | -6.8% | -4.9% | -15.6% |
| SION | SELL | 2025-11-24 | 2025-11-26 | $44.54 | $9.0M | -3.7% | +1.2% | -13.6% |
| CRVS | SELL | 2025-06-27 | 2025-07-01 | $4.16 | $9.8M | +13.3% | +8.6% | +89.6% |
| EWTX | BUY | 2025-04-03 | 2025-04-04 | $20.13 | $20.0M | +11.7% | +41.9% | +11.7% |
| SION | BUY | 2025-02-10 | 2025-02-10 | $18.00 | $9.9M | -12.1% | -23.9% | -42.6% |
| SPRY | SELL | 2024-08-26 | 2024-08-28 | $13.00 | $1.1M | -16.0% | +4.5% | +4.9% |
| SPRY | SELL | 2024-08-21 | 2024-08-23 | $13.14 | $16.6M | -10.4% | +7.5% | +2.1% |
| EWTX | BUY | 2024-01-23 | 2024-01-25 | $11.00 | $5.0M | +22.6% | +6.4% | +0.6% |
| ALPN | SELL | 2023-12-27 | 2023-12-29 | $18.54 | $57.3M | +4.5% | +38.8% | +110.7% |
| SPRY | BUY | 2023-08-29 | 2023-08-31 | $6.20 | $3.1M | -2.6% | -49.5% | -36.8% |
| EWTX | BUY | 2022-09-16 | 2022-09-16 | $10.32 | $10.0M | +9.1% | +0.8% | -20.8% |
| EWTX | BUY | 2022-05-18 | 2022-05-20 | $7.21 | $995K | -23.1% | -0.7% | +44.3% |
| JANX | SELL | 2021-12-29 | 2021-12-30 | $20.30 | $820K | -1.2% | -20.9% | -24.3% |
| JANX | SELL | 2021-12-21 | 2021-12-23 | $19.00 | $2.3M | -11.1% | -34.0% | -28.9% |
| JANX | SELL | 2021-12-16 | 2021-12-17 | $19.07 | $7.5M | +1.9% | -24.3% | -16.8% |
| CRVS | SELL | 2021-09-20 | 2021-09-22 | $6.09 | $13.5M | -33.4% | -38.0% | -63.0% |
| ALPN | BUY | 2021-09-17 | 2021-09-21 | $9.40 | $19.0M | +8.9% | -0.5% | +28.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| SION | 2,469,959 | $9.7M |
| PMVP | 4,500,076 | $5.4M |
| DNAI | 1,725,790 | $2.7M |
| CRVS | 120,000 | $1.1M |
| SPRY | 153,195 | $614K |
| ADAP | 4,901,310 | $269K |
| RBM | 34,291 | — |
| Total | $686.3M |
Shares reported on the most recent Form 4, priced at the 2026-07-09 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 7 | 7 | 7 |